The possibility of exploring basic biological phenomena requires the development of new and efficient bioimaging tools. These should ideally combine the feasibility of production (potentially through the use of green chemistry) together with high targeting efficiency, low cytotoxicity, and optimal contrast characteristics. In this work, we developed nanovesicles based on cardanol, a natural and renewable byproduct of the cashew industry, and a fluorescent reporter was encapsulated in them through an environment-friendly synthesis method. In vitro investigations demonstrated that the cardanol nanovesicles are efficiently taken-up by both professional and non-professional phagocytic cells, which have been modeled in our approach by macrophages and HeLa cells, respectively. Co-localization studies show high affinity of the nanovesicles towards the cell plasma membrane. Moreover, metabolic assays confirmed that these nanostructures are biocompatible in a specific concentration range, and do not promote inflammation response in human macrophages. Stability studies carried out at different temperatures showed that the nanovesicles are stable at both 37 C and 20 C, while the formation of aggregates occurs when the nanodispersion is incubated at 4 C. The results demonstrate the high potential of fluorescent cardanol nanovesicles as a green bioimaging tool, especially for investigating cell membrane dynamics.
Introduction
In the past few decades, nanotechnology has represented a unique opportunity to explore new tools for biomedical applications, especially in bio-imaging and nanomedicine-based therapies. [1] [2] [3] [4] [5] The advancements in materials science have contributed indeed to developing novel drug delivery systems, some of them being approved for clinical use. Examples includebut are not restricted to -polymer nanoparticles (e.g., PEGylated proteins), liposome/micellar/protein formulations loaded with drugs (such as the liposomal amphotericin B lipid complex, micellar estradiol, and albumin-bound paclitaxel nanoparticles), and nanocrystals (e.g., dextran coated SPIONS).
6 Different nanocarriers have thus been developed so far to deliver specic payloads. 7 The aim is to improve the drug solubility/stability, and to combine high level of absorption in tissues together with a sustained and controlled release. In this respect, many natural products known to possess anticancer or antimicrobial properties need to be incorporated within nanoparticles to increase their bioavailability, as well as to reduce potential side effects. 8 Degradable natural or synthetic polymers, and more sustainable polymers from renewable resources, have thus been broadly exploited as preferential starting materials for developing delivery platforms. [9] [10] [11] Dextran nanovesicles responsive to acidic pH and/ or esterase, and chitosan nanoparticles for cancer targeting are only some examples.
12-14 A recent trend is also the development of drug-loaded bioactive nanocarriers made from natural oils (such as grapeseed oil, sh oil and laurel leaf oil) and surfactant mixtures, as these are able to reduce harmful free radicals and eradicate cancer cells. 15 Among the plethora of nature-inspired products that can be exploited as a backbone for delivery systems, cardanol (CA) has received great attention. This is due to the CA structural features that make it suitable for feasible chemical modications. CA is a renewable raw material obtained as a byproduct of the cashew industry by distillation of the cashew nut shell liquid (CNSL). Several data proved that CNSL and its derivatives possess interesting in vitro and in vivo biological functions, including antioxidant, antimicrobial, anti-cancer and larvicidal activities. [16] [17] [18] [19] [20] [21] CA is able to form a stable nanovesicle dispersion upon combination with cholesterol, 22, 23 showing good antioxidant and cytotoxic properties, 24 and a potential stabilization capability towards the encapsulated molecules. 25 A new challenge nowadays is, hence, the possibility of creating a biocompatible drug delivery system starting from waste materials, which can also be potentially used as a bioimaging tool.
26-30
In this framework, we aimed here to produce CA-based nanovesicles, and to use them as a platform to develop a green system for imaging biological specimens. We demonstrated that CA-nanovesicles (CANVs) can efficiently encapsulate rhodamine B (RhB) through an organic solvent-free procedure, and be delivered to human macrophages (MF) and HeLa cells, which show an efficient active uptake process. Moreover, we conrmed that these CANVs are biocompatible up to specic concentrations, and do not induce any inammation process in MF. Stability studies of the CANVs were performed at three different temperatures (37, 20 
B. Preparation of cardanol-based nanovesicles
RhB dye was mixed with CA, CH (molar ratio 0.04 : 1 : 0.6, respectively), and glass beads (10 g, diameter of 4 mm) by mechanical stirring at 200 rpm at 90 C for 1 h to form a lipid lm on the ask's wall. The resulting lm was hydrated with 40 mL of borate buffer at pH 9.0, preheated at 50 C, under mechanical stirring (800 rpm), and nally heated at 90 C for 1 h. Then, the obtained vesicular nanodispersion was sonicated for 15 min at 60 C, and then centrifuged (7000 rpm for 15 min)
to collect the supernatant as the sample. Purication of the nanodispersion from non-entrapped RhB was performed by exhaustive dialysis. The sample was transferred into a dialysis tubing cellulose membrane (12 kDa) and then sealed at both ends with clips and dialyzed against borate buffer solution, pH 9.0, for some days. Fresh buffer solution was replaced every day, and the free RhB was monitored at 554 nm through UV-vis measurements using a Jasco V-660 spectrophotometer until disappearance of the signal. A sample without dye was prepared with the same procedure as that for the blank reference.
C. Dynamic light scattering analysis
Measurements of dynamic light scattering (DLS) and electrophoretic light scattering were both carried out on a Malvern Zetasizer Nano ZS90 on samples diluted with UP water to establish the size and z-potential of nanovesicles. The hydrodynamic diameter (d) of the vesicle nanodispersion was determined at 25 C measuring the autocorrelation function at a 90 scattering angle. Each d value is the average of three separate measurements. The z-potential values of nanovesicles were determined at 25 C from an average of 3 measurements. The voltage ramps were performed according to the DLS manufacturer instructions.
D. HPLC-DAD-MS analysis
Separation and quantication of nanocarrier components (CA and CH) were performed on an Agilent Technologies (Waldbronn, Germany) modular model 1200 system, consisting of a vacuum degasser, a binary pump, an autosampler, a xed-temperature column compartment, and a diode array detector (DAD). Natural CA extract is a mixture of compounds and was used as such as a standard to develop a calibration curve in the range 10-1000 mg L À1 . For CA quantication nanovesicles were lysed by adding 5 mL of MeOH to 1 mL of samples, then dried, resuspended in 1 mL of CH 3 CN, and passed through a 0.22 mm nylon lter before injection. The chromatograms were recorded using Agilent Mass Hunter soware (rev. B.06.00). Chromatography separation was carried out on a 150 Â 4.6 mm i.d., 5 mm Gemini C18 column set at 25 C. The mobile phase was composed of water/acetic acid 0.1% v/v (solvent A) and CH 3 CN (solvent B). The chromatograms were acquired at a wavelength of 280 nm working at a ow rate of 0.8 mL min À1 , with the following gradient: 0 min, 50% B; 20 min, 100% B; and 32 min, 100% B. Three injections were performed for each sample, and the results are the average of those values. Qualitative analyses of CA were carried out aer chromatographic separation using the same system equipped with a 6540 quadrupole time-of-ight (QTOF) mass analyzer with an electrospray ionization (ESI) source. The HPLC-ESI-MS analyses of the CA components were performed both in negative-ion mode and in positive-ion mode. 25 Quantication of CH was performed using a curve in the range 10-1000 mg L À1 . Nanovesicles were lysed by adding 5 mL of MeOH to 1 mL of samples, then dried, resuspended in 1 mL of mixed solvent CH 3 CN/MeOH/IPA (7 : 3 : 1, v/v/v) and passed through a 0.22 mm nylon lter before injection. The chromatograms were recorded using the Agilent Mass Hunter soware mentioned above. Chromatography separation was carried out on a 150 Â 4.6 mm i. 
where C days is the analyte concentration determined at different days, whereas C 0 is the analyte concentration determined on the fresh sample.
F. Cell uptake and metabolic assay
HeLa cells were cultured and maintained using DMEM containing 10% (v/v) fetal calf serum, 2 mM L-glutamine, 100 mg mL À1 streptomycin and 100 IU mL À1 penicillin. Cells were cultured at 37 C/95% air/5% CO 2 . Cells were periodically subcultured using trypsin-EDTA solution 0.25% for the detachment process and centrifuged at 300g for 5 min for the pellet collection. THP-1 cells were cultured and maintained in RPMI-1640 medium, supplemented with 10 mM HEPES buffer, 10% (v/v) fetal calf serum, 2 mM L-glutamine, 100 mg mL À1 streptomycin and 100 IU mL À1 penicillin. THP-1 monocytes were differentiated to macrophages through incubation with 5 ng mL À1 PMA for 48 hours. 32 We chose this PMA concentration as it does not modify the regulation of stress-and inammation-related genes. 33 For the metabolic assay, the MTT method was used. Briey, cells were seeded at a concentration of 5 Â 10 3 cells per well in a 96 well plate overnight. Increasing concentrations of CANVs were then added in the growth media, namely 5, 10, 30, 50, and 70 mg mL À1 , for 24 and 48 hours. The growth medium was then removed, and the tetrazolium blue salt was added for 2 hours. An acidied solution of isopropanol was then added to dissolve the water-insoluble MTT formazan. The solubilized blue crystals were measured colorimetrically at 570 nm (plate reader ELx800, BioTek). For uptake imaging analyses, HeLa and THP-1 cells were seeded on glass-bottom Petri dishes (Ibidi) at a concentration of 5 Â 10 3 cells per well, and incubated with RhB-labeled CANVs (0.1 mg mL À1 ) for 24 and 48 hours, followed by 3 steps of PBS washing. Cells were then stained with DAPI for nuclear staining, and far-red CellMask for cell membrane staining and imaged with a confocal microscope (Leica SP8). For the uptake quantication, 10 different regions of the Petri dishes were captured, and the uorescent signal was normalized to the nuclear intensity signal (using ImageJ).
G. Quantication of M(F) inammation levels
For the quantication of MF inammation levels, THP-1 blue NF-kB reporter cells were used. These cells are stably transfected and express a secreted embryonic alkaline phosphatase (SEAP) reporter gene driven by an IFN-beta minimal promoter fused to ve copies of the NF-kB transcription factor, which promotes cytokine production. The translocation of NFkB from the cytosol to the nucleus induces the release of the SEAP phosphatase, whose activity can be monitored colorimetrically. THP-1 blue NF-kB reporter cells were differentiated into MF as previously described, and then incubated with 200 ng mL À1 bacterial LPS as a positive control, and with 30 mg mL À1 CANVs for 24 and 48 hours. 20 mL of media were then removed and incubated with the incubation media, according to the manufacturer's instructions. The quantication of media color change was performed with a spectrophotometer (plate reader ELx800, BioTek) by reading at 570 nm.
Results and discussion
The CA used as the main constituent of the green nanocarrier by a mixture of differently (un)saturated compounds ( Fig. 1) . Hence, HPLC-DAD-MS analyses were preliminarily used to determine the CA composition. 25 Four main components were found, corresponding to three unsaturated components, 3- that the morphology of the green nanocarriers is characterized by a very regular spherical structure, as we have already reported in our previous studies. 23, 24 Aer analyzing the physicochemical parameters of the "green" CANVs, and their stability as a function of the environmental temperature, we addressed their interactions with cells. As model systems, we used human cervical cancer (HeLa) cells, and leukemic monocytes (THP-1), differentiated to a macrophage (MF) phenotype (see the Experimental section). We encapsulated RhB under solvent-free conditions within the CANVs. RhB-encapsulated CANVs were incubated with cells, and the kinetics of uptake were studied by confocal microscopy (Fig. 3) . We have observed an increase in the relative uorescence intensity in HeLa cells (i.e., the uo-rescence of RhB-encapsulated CANVs normalized by the number of cells) from ca. 0.7 to 1, corresponding to 24 and 48 hours of incubation, respectively (Fig. 3A) . Moreover, the quantication of the Pearson coefficient, which is a measure of the spatial overlap between two different signals, conrms that there is almost 85% signal co-localization between the nanovesicles and the plasma membrane. The value rises up to ca. 90% aer 48 hours of incubation. This suggests that the nanovesicles tend to interact with the plasma membrane, and while some of these will undergo an internalization process through endocytosis, a signicant number of nanovesicles remain at the membrane level. We have also observed similar uptake proles for MF, as the normalized uorescence intensity of the RhB-encapsulated CANVs increased from ca. 0.6 to 1, which corresponds to 24 and 48 hours of incubation with cells (Fig. 3B) . In this case, however, the Pearson coefficient had lower values with respect to HeLa cells. In particular, it was about 62% aer 24 hours and ca. 70% aer 48 hours of incubation with nanovesicles (Fig. 3B ). This would suggest that the nanovesicles interact less with the plasma membrane of MF compared to the stronger interaction with the membrane of HeLa cells. This can be ascribed to the different uptake processes of the two cells. HeLa cells engulf materials only by endocytic processes while MF combine endocytosis with phagocytosis (typical of professional phagocytes). This means, in turn, that the dwelling time of nanoparticles at the plasma membrane level in MF might be lower compared to that in HeLa because MF are much more efficient in performing nanovesicle engulfment. Aer analyzing the uptake prole of the nanovesicles, we addressed their effects on both cells. Hence, we carried out metabolic assays to test the potential toxicity of the CANVs as a function of concentration and incubation time. CANVs did not induce any decrease in cell viability at 5, 10, and 30 mg mL À1 aer 24 hours of incubation with HeLa cells (Fig. 4A, le) , while the viability dropped to ca. 40% upon incubation with 50 mg mL À1 (hence close to their IC 50 ). The nanovesicles displayed signicant toxicity at 70 mg mL À1 , where no viable HeLa cells were detected (Fig. 4A, le) . Similarly, CANVs did not induce toxicity aer 48 hours at 5 and 10 mg mL À1 , while at 30 and 50 mg mL À1 they were slightly more toxic with respect to the 24 hour case. Also in this case, 70 mg mL
À1
was lethal to HeLa. With respect to MF, signicant toxicity was detected starting from 50 mg mL À1 CANVs aer 24 and 48 hours of incubation (Fig. 4A, right) . As for HeLa, 70 mg mL À1 CANVs resulted also lethal for MF. We then went deeper into the potential mechanisms of toxicity and tried to understand whether nanovesicles induce inammation in MF. To do this, we used THP1-NF-kB reporter cells, which are extremely powerful to monitor and quantify the level of translocation of the transcription factor NF-kB from the cytosol to the nucleus. This translocation occurs when MF have to start an inammation process upon external stimuli (like the presence of bacterial lipopolysaccharides -LPS). The nuclear translocation of NF-kB induces then the production of cytokines, which are the key players in inammation. The THP1-NF-kB reporter cells used in this work carry a stable integration of an NF-kB-inducible SEAP reporter construct. Hence, we are able to quantify NF-kB translocation/activation through the quanti-cation of the SEAP activity. We thus incubated MF with LPS as a positive control, as it induces a full NF-kB translocation from the cytosol to the nucleus, and we normalized the other conditions according to this treatment (Fig. 4B) . We did not detect any signicant increase in the SEAP activity under all the conditions tested (10, 30, and 50 mg mL À1 CANVs), compared to control untreated cells. This indicates that CANVs do not promote inammation, which is absolutely crucial for any biomedical application of these nanosystems.
Conclusions
The current need for exploring and deciphering basic biological phenomena requires the development of new and effective bioimaging nanotools. While doing this, nature-inspired products should be used for the design of nano-vehicles as they represent a safe, inexpensive, renewable and theoretically unlimited resource. In this context, we exploited a natural byproduct of the cashew industry, cardanol, and combined it with cholesterol for the development of cardanol-nanovesicles by a green chemistry approach. We encapsulated the nano-vesicles with a uorescent dye (rhodamine) and demonstrated that human HeLa and THP-1 (macrophages) cells efficiently uptake them. The nanovesicles have also been demonstrated to uniformly stain the cell plasma membrane, a process having high impact in imaging-based applications. Finally, we demonstrated also that CANVs are biocompatible in a specic concentration range, and do not induce any inammation process in macrophages.
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